Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for SMMNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -646.17M
March 31, 2026 -610.28M
December 31, 2025 -349.18M
September 30, 2025 -1.124B
June 30, 2025 -791.24M
March 31, 2025 -435.57M
December 31, 2024 -526.95M
September 30, 2024 -389.83M
June 30, 2024 -890.97M
March 31, 2024 221.36M
December 31, 2023 -348.44M
September 30, 2023 -406.13M
June 30, 2023 272.55M
March 31, 2023 -388.93M
December 31, 2022 114.25M
September 30, 2022 -307.26M
June 30, 2022 -181.38M
March 31, 2022 -365.28M
December 31, 2021 -660.66M
September 30, 2021 -339.27M
Date Value
June 30, 2021 15.91B
March 31, 2021 -379.85M
December 31, 2020 -825.00M
September 30, 2020 -696.53M
June 30, 2020 -578.11M
March 31, 2020 -144.35M
December 31, 2019 1.279B
September 30, 2019 -525.58M
June 30, 2019 -162.33M
March 31, 2019 -191.34M
December 31, 2018 346.88M
September 30, 2018 -343.91M
June 30, 2018 -234.15M
March 31, 2018 -311.20M
December 31, 2017 492.13M
September 30, 2017 -467.32M
June 30, 2017 -454.94M
March 31, 2017 -304.83M
December 31, 2016 -186.43M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Inspecs Group Plc --
SheerVision, Inc. --
Carl Zeiss Meditec AG --
Organogenesis Holdings, Inc. -12.50M
Drägerwerk AG & Co. KGaA -50.42M